Fosun International, a Chinese multinational conglomerate holding company involved in pharmaceutical production, announced on Tuesday that it has received the Outstanding ESG Award as well as awards for Best in ESG Practices and Best in ESG Report at the TVB ESG Awards ceremony, hosted by Television Broadcasts Limited (TVB) held at the Hong Kong Convention and Exhibition Centre.

A total of five organisations received the Outstanding ESG Award, including the Drainage Services Department of the Government of the Hong Kong SAR, CLP Power Hong Kong Limited, Chinachem Group and Crystal International Group as well as Fosun.

Angel Sze, Fosun company secretary and head of the ESG Management Committee, said: "Since its establishment, Fosun has remained dedicated to its original aspiration of 'Contribution to Society' and strives to create a positive impact through business. For instance, in our pharmaceutical business, we focus on technology innovation and have made significant breakthroughs in cancer treatment. The CAR-T cell therapy product Yi Kai Da (ejilunsai injection), developed by Fosun Kite, is the first CAR-T cell therapy approved for marketing in the Chinese mainland, bringing lymphoma patients more treatment options and hope for recovery."